- Home
- CISO vs LSTA Comparison
CISO vs LSTA Comparison
Compare CISO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- LSTA
- Stock Information
- Founded
- CISO 2015
- LSTA 1980
- Country
- CISO United States
- LSTA United States
- Employees
- CISO N/A
- LSTA N/A
- Industry
- CISO Computer Software: Prepackaged Software
- LSTA Misc Health and Biotechnology Services
- Sector
- CISO Technology
- LSTA Health Care
- Exchange
- CISO Nasdaq
- LSTA Nasdaq
- Market Cap
- CISO 31.4M
- LSTA 20.9M
- IPO Year
- CISO N/A
- LSTA N/A
- Fundamental
- Price
- CISO $1.11
- LSTA $2.79
- Analyst Decision
- CISO
- LSTA Strong Buy
- Analyst Count
- CISO 0
- LSTA 2
- Target Price
- CISO N/A
- LSTA $23.50
- AVG Volume (30 Days)
- CISO 786.4K
- LSTA 56.2K
- Earning Date
- CISO 11-17-2025
- LSTA 11-06-2025
- Dividend Yield
- CISO N/A
- LSTA N/A
- EPS Growth
- CISO N/A
- LSTA N/A
- EPS
- CISO N/A
- LSTA N/A
- Revenue
- CISO $28,792,765.00
- LSTA $1,070,000.00
- Revenue This Year
- CISO N/A
- LSTA N/A
- Revenue Next Year
- CISO N/A
- LSTA N/A
- P/E Ratio
- CISO N/A
- LSTA N/A
- Revenue Growth
- CISO N/A
- LSTA N/A
- 52 Week Low
- CISO $0.30
- LSTA $1.87
- 52 Week High
- CISO $3.84
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- CISO 46.73
- LSTA 62.33
- Support Level
- CISO $1.16
- LSTA $2.43
- Resistance Level
- CISO $1.29
- LSTA $2.81
- Average True Range (ATR)
- CISO 0.12
- LSTA 0.19
- MACD
- CISO -0.02
- LSTA 0.03
- Stochastic Oscillator
- CISO 15.91
- LSTA 73.61
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.